Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Vaccine
|
June 2, 1998
Effect of route of immunisation and adjuvant on T and B cell epitope recognition within a streptococcal antigen
S M Todryk, C G Kelly, T Lehner
Expert Opinion on Investigational Drugs
|
July 5, 2005
The role of herpes simplex virus thymidine kinase in the treatment of solid tumours
M J Perry, S M Todryk, A G Dalgleish
Immunology
|
January 1, 1996
Induction of immune responses to functional determinants of a cell surface streptococcal antigen
S M Todryk, C G Kelly, G H Munro, et al.
Gut
|
November 21, 1998
Can immunotherapy by gene transfer tip the balance against colorectal cancer?
S M Todryk, H Chong, R G Vile, et al.
Immunology
|
March 22, 2001
Efficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines
S M Todryk, L J Birchall, R Erlich, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
The immunotherapy of prostate cancer
A G Dalgleish, M J A Perry, J D Eaton, et al.
Journal of Immunological Methods
|
February 27, 2001
CD40 ligation for immunotherapy of solid tumours
S M Todryk, A L Tutt, M H Green, et al.
BJU International
|
November 9, 2000
Allogeneic whole-tumour cell vaccination in the rat model of prostate cancer
D Hrouda, S M Todryk, M J Perry, et al.
Prostate Cancer and Prostatic Diseases
|
March 29, 2003
Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies
H S Pandha, L H Stockwin, J Eaton, et al.
Gene Therapy
|
April 25, 2001
Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques
J D Eaton, M J Perry, S M Todryk, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Vaccine
|
June 2, 1998
Effect of route of immunisation and adjuvant on T and B cell epitope recognition within a streptococcal antigen
S M Todryk, C G Kelly, T Lehner
Expert Opinion on Investigational Drugs
|
July 5, 2005
The role of herpes simplex virus thymidine kinase in the treatment of solid tumours
M J Perry, S M Todryk, A G Dalgleish
Immunology
|
January 1, 1996
Induction of immune responses to functional determinants of a cell surface streptococcal antigen
S M Todryk, C G Kelly, G H Munro, et al.
Gut
|
November 21, 1998
Can immunotherapy by gene transfer tip the balance against colorectal cancer?
S M Todryk, H Chong, R G Vile, et al.
Immunology
|
March 22, 2001
Efficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines
S M Todryk, L J Birchall, R Erlich, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
The immunotherapy of prostate cancer
A G Dalgleish, M J A Perry, J D Eaton, et al.
Journal of Immunological Methods
|
February 27, 2001
CD40 ligation for immunotherapy of solid tumours
S M Todryk, A L Tutt, M H Green, et al.
BJU International
|
November 9, 2000
Allogeneic whole-tumour cell vaccination in the rat model of prostate cancer
D Hrouda, S M Todryk, M J Perry, et al.
Prostate Cancer and Prostatic Diseases
|
March 29, 2003
Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies
H S Pandha, L H Stockwin, J Eaton, et al.
Gene Therapy
|
April 25, 2001
Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques
J D Eaton, M J Perry, S M Todryk, et al.
Page
of 2